This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Surgical Care Affiliates, DaVita CEOs agreed to freeze out each other’s employees, former SCA hirer says at US trial

By Michael Acton ( April 5, 2022, 22:08 GMT | Insight) -- Former Surgical Care Affiliates CEO Andrew Hayek struck a secretive no-poach deal with former colleague Kent Thiry at DaVita that prevented high-level employees from even being considered for roles, SCA’s former chief talent officer said at a US no-poach criminal trial in Colorado. SCA’s Hayek saw the agreement as "very important" due to his close relationship with Thiry and adhered to it even though DaVita’s employees were an important source of potential talent, Bridget Fanning told the jury in Denver.Former Surgical Care Affiliates Chief Executive Andrew Hayek struck a secretive no-poach deal with former colleague Kent Thiry at DaVita that prevented high-level employees from even being considered for roles, SCA’s former chief talent officer said at a US no-poach criminal trial in Colorado today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections